Use of aspirin associates with longer primary patency of hemodialysis grafts

Journal of the American Society of Nephrology

Volumn 22, Issue 4, 2011, Pages 773-781

  Dixon, Bradley S ^a,b   Beck, Gerald J ^c   Dember, Laura M ^d   Vazquez, Miguel A ^e   Greenberg, Arthur ^f   Delmez, James A ^g   Allon, Michael ^h   Himmelfarb, Jonathan ⁱ   Hu, Bo ^c   Greene, Tom ^j   Radeva, Milena K ^c   Davidson, Ingemar J ^e   Ikizler, T Alp ^k   Braden, Gregory L ^l   Lawson, Jeffrey H ^m   Cotton, James R ⁿ   Kusek, John W ^o   Feldman, Harold I ^p  

^a UNIVERSITY OF IOWA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h University of Alabama at Birmingham   (United States)

ⁱ UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^k VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^l BAYSTATE MEDICAL CENTER   (United States)

^m Department of Surgery ^*  (United States)

ⁿ Tyler Nephrology Associates   (United States)

^o NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^p UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS DIPYRIDAMOLE; ALBUMIN; HEMOGLOBIN; PLACEBO; SERUM ALBUMIN;

ADULT; ARTICLE; BLEEDING; BODY MASS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DRUG FATALITY; FEMALE; FOLLOW UP; GRAFT PATENCY; HEMODIALYSIS; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VASCULAR ACCESS; VENOUS THROMBOEMBOLISM;

EID: 79953321405     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010060582     Document Type: Article

References (21)

1. Feldman HI, Kobrin S, Wasserstein A: Hemodialysis vascular access morbidity. J Am Soc Nephrol 7: 523-535, 1996
2. Besarab A, Work J: Clinical practice guidelines for vascular access. Am J Kidney Dis 48[Suppl 1]: S176-S247, 2006
3. Gibson KD, Gillen DL, Caps MT, Kohler TR, Sherrard DJ, Stehman-Breen CO: Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J Vasc Surg 34: 694-700, 2001 (Pubitemid 33664921)
4. U.S. Renal Data System: 2008 Annual Data Report: Atlas of End-stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 2008
5. Kanterman RY, Vesely TM, Pilgram TK, Guy BW, Windus DW, Picus D: Dialysis access grafts: Anatomic location of venous stenosis and results of angioplasty. Radiology 195: 135-139, 1995
6. Dixon BS, Beck GJ, Vazquez MA, Greenberg A, Delmez JA, Allon M, Dember LM, Himmelfarb J, Gassman JJ, Greene T, Radeva MK, Davidson IJ, Ikizler TA, Braden GL, Fenves AZ, Kaufman JS, Cotton JR Jr, Martin KJ, McNeil JW, Rahman A, Lawson JH, Whiting JF, Hu B, Meyers CM, Kusek JW, Feldman HI, Group, DACS: Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med 360: 2191-2201, 2009
7. Dixon BS, Beck GJ, Dember LM, Depner TA, Gassman JJ, Greene T, Himmelfarb J, Hunsicker LG, Kaufman JS, Lawson JH, Meyers CM, Middleton JP, Radeva M, Schwab SJ, Whiting JF, Feldman HI: Design of the dialysis access consortium (DAC) aggrenox prevention of access stenosis trial. Clin Trials 2: 400-412, 2005 (Pubitemid 41586025)
8. Sreedhara R, Himmelfarb J, Lazarus JM, Hakim RM: Anti-platelet therapy in graft thrombosis: Results of a prospective, randomized, double-blind study. Kidney Int 45: 1477-1483, 1994 (Pubitemid 24135036)
9. Kaufman JS, O'Connor TZ, Zhang JH, Cronin RE, Fiore LD, Ganz MB, Goldfarb DS, Peduzzi PN: Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis. J AmSoc Nephrol 14: 2313-2321, 2003 (Pubitemid 37052378)
10. Saran R, Dykstra DM, Wolfe RA, Gillespie B, Held PJ, Young EW: Association between vascular access failure and the use of specific drugs: The Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 40: 1255-1263, 2002 (Pubitemid 35403138)
11. Yevzlin AS, Conley EL, Sanchez RJ, Young HN, Becker BN: Vascular access outcomes and medication use: A USRDS study. Semin Dial 19: 535-539, 2006 (Pubitemid 44736562)
12. Domoto DT, Bauman JE, Joist JH: Combined aspirin and sulfinpyrazone in the prevention of recurrent hemodialysis vascular access thrombosis. Thromb Res 62: 737-743, 1991
13. Trimarchi H, Young P, Forrester M, Schropp J, Pereyra H, Freixas E: Clopidogrel diminishes hemodialysis access graft thrombosis. Nephron Clin Pract 102: c128-c132, 2006 (Pubitemid 43289528)
14. Harter HR, Burch JW, Majerus PW, Stanford N, Delmez JA, Anderson CB, Weerts CA: Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. N Engl J Med 301: 577-579, 1979 (Pubitemid 10226452)
15. Kuji T, Masaki T, Goteti K, Li L, Zhuplatov S, Terry CM, Zhu W, Leypoldt JK, Rathi R, Blumenthal DK, Kern SE, Cheung AK: Efficacy of local dipyridamole therapy in a porcine model of arteriovenous graft stenosis. Kidney Int 69: 2179-2185, 2006 (Pubitemid 43882104)
16. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A: European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 143: 1-13, 1996 (Pubitemid 26402780)
17. Halkes PH, van Gijn J, Kappelle LJ, Koudstaal PJ, Algra A: Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): Randomised controlled trial. Lancet 367: 1665-1673, 2006
18. Hiremath S, Holden RM, Fergusson D, Zimmerman DL: Antiplatelet medications in hemodialysis patients: A systematic review of bleeding rates. Clin J Am Soc Nephrol 4: 1347-1355, 2009
19. Gradzki R, Dhingra RK, Port FK, Roys E, Weitzel WF, Messana JM: Use of ACE inhibitors is associated with prolonged survival of arteriovenous grafts. Am J Kidney Dis 38: 1240-1244, 2001 (Pubitemid 34193109)
20. Miller PE, Carlton D, Deierhoi MH, Redden DT, Allon M: Natural history of arteriovenous grafts in hemodialysis patients. Am J Kidney Dis 36: 68-74, 2000 (Pubitemid 30432566)
21. Lin DY, Wei LJ, Ying Z: Checking the Cox model with cumulative sums of martingale-based residuals. Biometrika 80: 557-572, 1993